logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Eric Padron

h lee moffitt cancer center & research institute
H指数:53
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)

多组学验证骨髓增生异常综合征(MDS)分子分类的临床相关性

HemaSphere
IF14.6
2026-07-280
OAAI
Giulia Maggioni; Gabriele Todisco; Elisabetta Sauta; Luca Lanino; Somedeb Ball; Jan P. Bewersdorf; Tariq Kewan; Najla H. Al Ali; Pierre Fenaux; Uwe Platzbecker; Valeria Santini; Zhuoer Xie; Andrew M. Brunner; Andrew T. Kuykendall; John M. Bennett; Rena Buckstein; Rafael Bejar; Hetty E. Carraway; Amy E. DeZern; Elizabeth A. Griffiths; Stephanie Halene; Robert P. Hasserjian; Alan F. List; Sanam Loghavi; Olatoyosi Odenike; Eric Padron; Mrinal M. Patnaik; Gail J. Roboz; Maximilian Stahl; Mikkael A. Sekeres; David P. Steensma; Michael R. Savona; Justin Taylor; Mina L. Xu; David A. Sallman; Stephen D. Nimer; Christopher S. Hourigan; Andrew H. Wei; Alessia Campagna; Marta Ubezio; Elena Riva; Denise Ventura; Nicole Pinocchio; Matteo Zampini; Alessandro Buizza; Antonio Russo; Francesco Pesce; Saverio D'Amico; Gianluca Asti; Mattia Delleani; Erica Travaglino; Cristina A. Tentori; Ivan Ferrari; Alessandra Crespi; Giulia Figini; Maria Di Matteo; Matteo Brindisi; Nicla Manes; Chiara Milanesi; Laura Crisafulli; Francesca Ficara; Gastone Castellani; Uma M. Borate; Fabio Efficace; Steven D. Gore; Tae K. Kim; Maria Diez-Campelo; Arjan A. van de Loosdrecht; Navel Daver; Maria Rozman; Alberto Orfao; Sa A. Wang; Kathryn Foucar; Marcelo Iastrebner; Phillip Scheinberg; Yasushi Miyazaki; Yazan F. Madanat; Aref Al-Kali; Moshe Mittelmann; Thomas Cluzeau; Lionel Ades; Ulrich Germing; Guillermo Garcia-Manero; Shahram Kordasti; Torsten Haferlach; Amer M. Zeidan; Rami S. Komrokji; Matteo G. Della Porta; An international study on behalf of GenoMed4all, Synthema, and icMDS consortia
Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution

基于分子演化的骨髓增生异常综合征预后评分

NEJM Evidence
IF0
2026-05-262
PRE
Civettini, Ivan; Malighetti, Federica; Villa, Matteo; Crippa, Valentina; Aroldi, Andrea; Cavalca, Fabrizio; Graudenzi, Alex; Lanino, Luca; Maggioni, Giulia; Haferlach, Torsten; Fenaux, Pierre; Platzbecker, Uwe; Diez-Campelo, Maria; Borin, Lorenza Maria; Fumagalli, Monica; Zappaterra, Arianna; Manghisi, Beatrice; Al Ali, Najla H.; Sallman, David A.; Padron, Eric; Xie, Zhuoer; Chan, Onyee; Zeidan, Amer M.; Mologni, Luca; Piazza, Rocco; Komrokji, Rami S.; Della Porta, Matteo Giovanni; Gambacorti-Passerini, Carlo; Ramazzotti, Daniele
Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex

骨髓增生异常综合征及前体状态在种族、族裔和性别方面的临床、遗传和病理学变异

American Journal of Hematology
IF9.9
2026-03-290
OAAI
Nancy Gillis; Christelle Colin-Leitzinger; Yi-Han Tang; Michael Otterstatter; Seth Sherman; Ling Zhang; Lynn C. Moscinski; Mary Ellen Walker; Jeffrey S. Painter; Gregory A. Abel; Tareq Al Baghdadi; H. Joachim Deeg; James M. Foran; Steven D. Gore; Alexandra M. Harrington; Steven H. Kroft; Jane Jijun Liu; Wael Saber; Shamsuddin Virani; Rafael Bejar; R. Coleman Lindsley; Eric Padron; Matthew J. Walter; Rami Komrojki; Amy E. DeZern; Mikkael A. Sekeres
Performance of molecular scoring systems in hypomethylating agent-treated myelodysplastic neoplasms

分子评分系统在低甲基化药物治疗的骨髓增生异常肿瘤中的表现

Leukemia
IF13.4
2026-03-060
PRE
Kelly S. Chien; Ziyi Li; Luca Lanino; Najla Al Ali; Samuel Urrutia; Alex Bataller; Rashmi Kanagal-Shamanna; Sanam Loghavi; Yue Lyu; Ahmed Abdelhakeem; Tareq Abuasab; Emmanuel Almanza; Georgina Gener Ricos; Alexandre Bazinet; Alessia Campagna; Giulia Maggioni; Eric Padron; Zhouer Xie; Guillermo Montalban-Bravo; Nicholas J. Short; Elias J. Jabbour; Tapan M. Kadia; Farhad Ravandi; Gautam Borthakur; Courtney D. DiNardo; Danielle Hammond; Mahesh Swaminathan; Koji Sasaki; Xiao Qin Dong; Sherry A. Pierce; David Sallman; Hagop M. Kantarjian; Matteo G. Della Porta; Guillermo Garcia-Manero; Rami Komrokji
Exposure to Agent Orange and Association with Myelodysplastic Syndromes

暴露于橙剂及其与骨髓增生异常综合征的关联

Blood Advances
IF7.1
2026-03-020
OA
Mikkael A. Sekeres; Amy E. DeZern; Michael Otterstatter; Eric Padron; Tareq Al Baghdadi; James M. Foran; Rami S. Komrokji; Gregory A. Abel; Wael Saber; Steven D. Gore; Cecilia Lee; Rafael Bejar; Jane J. Liu; H. Joachim Deeg; Seth Sherman; R. Coleman Lindsley; Matthew J. Walter; Nancy Gillis
Modeling the evolutionary dynamics of clonal hematopoiesis

模拟克隆性造血的进化动力学

Nature Genetics
IF29
2026-02-160
PRE
Sadegh Marzban; Thomas Stiehl; Zhuoer Xie; Morten Andersen; Jordan Snyder; Johanne Gudmand-Høyer; Johnny T. Ottesen; Nathaniel V. Mon Père; Benjamin Werner; Weini Huang; Amy E. DeZern; Mikkael A. Sekeres; Matthew J. Walter; Eric Padron; Nancy Gillis; Jeffrey West
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study

《MDS自然病史研究中定义MDS及前体髓系疾病进展的一种新方法》

Blood Advances
IF7.1
2026-02-130
OAAI
Amy E. DeZern; Nancy Gillis; Michael Otterstatter; Gregory Abel; Eric Padron; Jh Deeg; Tareq Al Baghdadi; Jane Liu; Zhuoer Xie; Ling Zhang; Lynn Moscinski; Steven Kroft; Alexandra Harrington; James Foran; Rami Komrokji; Daniel Starczynowski; Steven Gore; Wael Saber; Rafael Bejar; R. C. Lindsley
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts Outcomes

移植后微小残留病（MRD）通过TP53双测序结合APR-246 + 去氧氟尿苷维持治疗预测预后

Blood Advances
IF7.1
2025-11-270
OAAI
David A. Sallman; Amy F. McLemore; Rami Komrokji; Hany Elmariah; Andrew T. Kuykendall; Nelli Bejanyan; Onyee Chan; Rawan Faramand; Joseph Pidala; Sean J. Yoder; Lia Perez; Taiga Nishihori; Eric Padron; Hugo Fernandez; Jeffrey E. Lancet; Asmita Mishra
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia

去甲基化药物与Venetoclax联合方案是老年（≥70岁）新诊断低危急性髓系白血病患者接受强化化疗的安全有效替代方案。

American Journal of Hematology
IF9.9
2025-08-070
PREAI
Somedeb Ball; Akriti G. Jain; Najla Al Ali; Luis E. Aguirre; Jan Philipp Bewersdorf; Andrew Kent; Ameera Rose; Alexander Hayden; Alexa Siddon; Jill Lykon; Ellen Madarang; David M. Swoboda; Eric Padron; Kendra Sweet; David A. Sallman; Jeffrey Lancet; Hetty E. Carraway; Justin Watts; Amer Zeidan; Daniel A. Pollyea; Rami S. Komrokji
XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53 Mutated Myeloid Malignancies

XPO1驱动对Eprenetapopt和Azacitidine的抵抗，并且可以在TP53突变的髓系恶性疾病中作为靶点

Blood
IF23.1
2025-08-050
PRE
Traci L. Kruer; Ariel Quintana; Hannah Newman; Meghan Ferrall-Fairbanks; Ling Zhang; Amy McLemore; Surendra Neupane; Qin Yang; Nana Adjoa Ben-Crentsil; Maria E. Balasis; Christopher Letson; Rami Komrokji; Sana Chaudhry; Tulasigeri M. Totiger; Joshua Traina; Maria E. Figueroa; Christopher B. Ryder; Thomas Cluzeau; Justin Taylor; David A. Sallman; Eric Padron
Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes

多个TET2突变在骨髓增生异常和骨髓增生性慢性粒单核细胞白血病亚型中均带来额外的生存益处

Leukemia
IF13.4
2025-06-240
PRE
Clifford M. Csizmar; Anuya Natu; Mark Gurney; Saubia Fathima; Ali Khalid A. Alsugair; Rashmi Kanagal-Shamanna; Sanam Loghavi; Alexandre Bazinet; Kelly Chien; Danielle Hammond; Courtney DiNardo; Tapan Kadia; Farhad Ravandi-Kashani; Naveen Pemmaraju; Koji Sasaki; Terra L. Lasho; Christy M. Finke; Aref Al-Kali; Hassan Alkhateeb; Kebede Begna; Naseema Gangat; Mehrdad Hefazi Torghabeh; Aasiya Matin; Abhishek A. Mangaonkar; Antoine N. Saliba; Ayalew Tefferi; Guillermo Garcia-Manero; Hagop M. Kantarjian; Rami S. Komrokji; Zhuoer Xie; Najla A. Ali; David Sallman; Eric Padron; Guillermo Montalban-Bravo; Mrinal M. Patnaik
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/SyndromesdRecommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

骨髓增生异常肿瘤/综合征的诊断和分类的当代方法国际骨髓增生异常肿瘤/综合征联合会 (MDS [icMDS]) 的建议

MODERN PATHOLOGY
IF5.5
2024-12-011
PRE
Aakash, Fnu; Gisriel, Savanah D.; Zeidan, Amer M.; Bennett, John M.; Bejar, Rafael; Bewersdorf, Jan Philipp; Borate, Uma M.; Boultwood, Jacqueline; Brunner, Andrew M.; Buckstein, Rena; Carraway, Hetty E.; Churpek, Jane E.; Daver, Naval G.; Dezern, Amy E.; Efficace, Fabio; Fenaux, Pierre; Figueroa, Maria E.; Garcia-Manero, Guillermo; Gore, Steven D.; Greenberg, Peter L.; Griffiths, Elizabeth A.; Halene, Stephanie; Hourigan, Christopher S.; Kim, Tae Kon; Kim, Nina; Komrokji, Rami S.; Kutchroo, Vijay K.; List, Alan F.; Little, Richard F.; Majeti, Ravindra; Nazha, Aziz; Nimer, Stephen D.; Odenike, Olatoyosi; Padron, Eric; Patnaik, Mrinal M.; Platzbecker, Uwe; Porta, Matteo G. Della; Roboz, Gail J.; Sallman, David A.; Santini, Valeria; Sanz, Guillermo; Savona, Michael R.; Sekeres, Mikkael A.; Stahl, Maximilian; Starczynowski, Daniel T.; Steensma, David P.; Taylor, Justin; Abdel-Wahab, Omar; Wei, Andrew H.; Xie, Zhuoer; Xu, Mina L.; Hasserjian, Robert P.; Loghavi, Sanam
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study

维尼托克联合低甲基化药物治疗慢性粒单核细胞白血病: 一项倾向评分匹配的多中心队列研究

LEUKEMIA
IF13.4
2024-11-120
PRE
Tremblay, Douglas; Csizmar, Clifford; DiNardo, Courtney D.; Ball, Somedeb; Rippel, Noa; Hammond, Danielle; Kadia, Tapan M.; Ravandi, Farhad; Chien, Kelly; Van Hyfte, Grace; Mazumdar, Madhu; Saliba, Antoine; Mangaonkar, Abhishek; Lasho, Terra; Al-Kali, Aref; Kremyanskaya, Marina; Feld, Jonathan; Silverman, Lewis R.; Komrokji, Rami; Mascarenhas, John; Padron, Eric; Garcia-Manero, Guillermo; Sallman, David A.; Patnaik, Mrinal M.; Montalban-Bravo, Guillermo
Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS)

骨髓增生异常综合征在MDS自然史研究（MDS NHS）中的进展

BLOOD
IF23.1
2024-11-050
PRE
Dezern, Amy E.; Otterstatter, Michael; Gillis, Nancy; Abel, Gregory A.; Al Baghdadi, Tareq; Bejar, Rafael; Deeg, H. Joachim; Foran, James M.; Komrokji, Rami S.; Lindsley, R. Coleman; Liu, Jane Jijun; Moscinski, Lynn C.; Saber, Wael; Zhang, Ling; Borchert, Christine; Padron, Eric; Sherman, Seth; Difronzo, Nancy; Walter, Matthew J.; Sekeres, Mikkael A.
Phase 1/1b Dose Escalation and Expansion of CPX-351 in Combination with Gemtuzumab Ozogamicin in Newly Diagnosed Acute Myeloid Leukemia

I期/II期剂量递增和扩展研究：CPX-351联合Gemtuzumab Ozogamicin治疗新诊断急性髓性白血病

BLOOD
IF23.1
2024-11-050
PRE
Chan, Onyee; Sweet, Kendra L.; Talati, Chetasi; Zahra, Fatima Tuz; Nardelli, Lisa Ann; Lamba, Jatinder K.; Kim, Jongphil; Song, Jinming; Xie, Zhuoer; Yun, Seongseok; Kuykendall, Andrew T.; Padron, Eric; Walker, Alison R.; Komrokji, Rami S.; Lancet, Jeffrey E.; Sallman, David

研究方向

暂未获取到该数据
R
Rami S. Komrokji
H 指数:68论文数:1,498被引数:1.8万
D
David A. Sallman
H 指数:46论文数:817被引数:9,080
J
Jeffrey E. Lancet
H 指数:62论文数:881被引数:1.5万
A
Alan F. List
H 指数:89论文数:1,027被引数:3.5万
M
Mrinal M. Patnaik
H 指数:72论文数:1,243被引数:1.9万
O
Onyee Chan
H 指数:19论文数:306被引数:1,800
N
Najla H. Al Ali
H 指数:24论文数:187被引数:2,477
K
Kendra Sweet
H 指数:35论文数:374被引数:5,576
N
Najla Al Ali
H 指数:23论文数:251被引数:2,037
A
Andrew Kuykendall
H 指数:25论文数:581被引数:2,824